Clinical Trials Logo

Clinical Trial Summary

The investigators hypothesize that cycling for 1 hour of exercise at 65% peak oxygen consumption (VO2peak) after sitting >13 hr/day (SIT+EX) will not be different in postprandial plasma insulin responses compared to the control of only sitting (SIT). Furthermore, the investigators hypothesize that the SIT and SIT+EX groups will have a less favorble insulin response compared to the physically active group after performing the same 1-hour exercise bout (ACTIVE+EX).


Clinical Trial Description

Twelve healthy, untrained male and female participants will complete three different trials in a randomized, crossover design, each occurring over 4 days with a 3-4 day interval between the trials. Each trial consists of 3 phases. The first two days will serve as a control phase (C1) that will allow for familiarization, followed by a 2-day intervention phase consisting of 2 days of sitting 13 h/d for both groups (D1- D2) (SIT+EX and ACTIVE+EX). On the evening of Day 2 the SIT+EX and ACTIVE+EX groups will cycle for 1 hour at 65% of VO2peak. On the morning of Day 3 participants in all conditions will ingest a drink containing 75-g of glucose and undergo a two-hour oral glucose tolerance test (OGTT). For all trials, participants will refrain from any exercise other than that described for the study.

One week prior to the initiation of the first trial, participants will visit the Human Performance Laboratory (HPL) for a 10 min exercise test to measure peak oxygen uptake while cycling (VO2peak). On the same day, participants will be instrumented with an activity monitor worn on their thigh to record time sitting, standing and lying as well as step count (activPal). During the two control day (C1), participants will be asked to refrain from any planned exercise but will be asked to walk or move between 6,000 - 7,500 steps per day, which is considered to be 'low level of physical activity'(31). During the intervention days (D1-D2), those completing SIT and SIT+EX conditions will be asked to remain seated throughout much of the day and achieve <3,000 steps, while those completing the ACTIVE+EX condition will be asked to break up their sitting with low-intensity physical activity, not exercise, and achieve >10,000 steps. However, the only difference between trials is that at 18:00 h during SIT+EX and ACTIVE+EX they will cycle for 1-hr at 65% VO2peak.

On the day of the OGTT (D3), participants will report to the laboratory at 07:00 h. Body weight will be measured. They will lay down for 5 minutes and a catheter will be inserted into an antecubital vein and a fasting blood sample will then be collected 10 min before consumption of high-glucose drink (75 g) composed of water and glucose monohydrate. Approximately 5 ml of blood will be collected at 10, 20, 30, 60, 90 and 120 min after ingestion. Approximately 60 ml of blood will be sampled during each of the three trials and thus the total will amount to approximately 180 ml (6 ounces, 12 tablespoons). This amounts to approximately 2-4% of a person's total blood volume.

All blood samples collected will be transferred to K2 EDTA collection tubes, centrifuged at 2,000 g for 15 minutes at 4◦C and then stored in -80◦C freezer until later analysis. During OGTT, participants will sit quietly reading, watching movies, and/or surfing the Internet. Participants will also be asked to keep a consistent sleep/wake cycle during the trials. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04195165
Study type Interventional
Source University of Texas at Austin
Contact Michael B Dial
Phone 8018915699
Email Michael.dial@utexas.edu
Status Recruiting
Phase N/A
Start date September 23, 2019
Completion date September 23, 2020

See also
  Status Clinical Trial Phase
Completed NCT02385591 - Innovative Physical Activity Interventions for Overweight Latinos N/A
Completed NCT02672215 - RCT Computer-tailored Intervention on Workplace Sitting N/A
Completed NCT02994134 - Exercise, Cognitive Function and Neuroplasticity in Healthy Adults N/A
Completed NCT03305731 - Activating Behavior for Lasting Engagement After Stroke N/A
Completed NCT03119610 - The Physiologic Effects of Intranasal Oxytocin on Sarcopenic Obesity Phase 1/Phase 2
Active, not recruiting NCT02467881 - Physical Activity and Sedentary Behavior Change; Impact on Lifestyle N/A
Completed NCT02342301 - Cardiometabolic Response to Sit-stand Workstations. N/A
Terminated NCT02254902 - Physical Activity and Education Program for Somali Women N/A
Completed NCT01975870 - A stAPP to a Healthier Lifestyle N/A
Completed NCT02024061 - Treatment of Pediatric Obesity (TOP) - A Multidisciplinary Approach Involving Adolescents and Their Peers N/A
Completed NCT02960750 - Effectiveness of a Workplace "Sit Less and Move More" Web-based Program in Spanish Office Employees (Walk@WorkSpain) N/A
Completed NCT00183014 - Caminemos! Trial to Increase Walking Among Sedentary Older Latinos N/A
Completed NCT04049162 - Blueberry Enhances Activity and Cognition Through Increased Vascular Efficiency N/A
Completed NCT03283904 - Active Schools: Skelmersdale N/A
Completed NCT03694951 - The Effect of Experimentally Decreasing Sedentary Behaviour on Subjective Well-being N/A
Enrolling by invitation NCT04019119 - Digital Intervention for the Modification of Lifestyles (iGame) N/A
Completed NCT03109535 - MapTrek for Sedentary Workers N/A
Completed NCT03993652 - Kids FIRST: Family-based Intervention to Reduce Snacking and Screen Time in Children N/A
Completed NCT00891514 - Trial of Aerobic Exercise Training in Stroke Survivors N/A
Completed NCT03236597 - Assessing the Effects Of Treadmill On LPA, Sitting Time, and Cardiovascular Risk N/A